Vaginal Intraepithelial Neoplasia: Clinical Trials

8 trials for Vaginal Intraepithelial Neoplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 4 unknown. 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 41Completed 1

Follow Vaginal Intraepithelial Neoplasia: new trials by email Literature Review of Vaginal Intraepithelial Neoplasia trials Research Report on Vaginal Intraepithelial Neoplasia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) - Cervical Intraepithelial Neoplasia, Cervical Cancer
UnknownJun Zhang13392021-04-132023-01-26
The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) - Cervical Intraepithelial Neoplasia, Cervical Cancer
UnknownJun Zhang6472021-03-302023-01-26
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) - Cervical Intraepithelial Neoplasia, Cervical Cancer
UnknownJun Zhang9792021-02-062023-01-26
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) / Cecolin® - Cervical Intraepithelial Neoplasia, Cervical Cancer
Phase 4CompletedXiamen Innovax Biotech Co., Ltd5402020-05-012022-06-29
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
3 doses of HPV 16/18 bivalent vaccine, 2 doses of HPV 16/18 bivalent vaccine - Cervical Intraepithelial Neoplasia, Cervical Cancer
CompletedJun Zhang9402017-07-012019-01-04
Longitudinal HPV Pap in CIN and VAIN
HPV test and Pap Smear - Cervical Intraepithelial Neoplasia, Hysterectomy
UnknownChang Gung Memorial Hospital6002017-07-012023-07-05
A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls
3 doses of HPV 16/18 bivalent vaccine, 2 doses of HPV 16/18 bivalent vaccine - Cervical Intraepithelial Neoplasia, Cervical Cancer
Phase 3CompletedJun Zhang9792015-12-052018-08-16
Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine
HPV Vaccine, HEV vaccine - Cervical Intraepithelial Neoplasia, Cervical Cancer
Phase 3CompletedXiamen University73722012-11-222020-02-24

Narrower conditions

Uterine Cervical Dysplasia (8)  ·  Persistent Infection (7)  ·  Uterine Cervical Neoplasms (7)  ·  Papillomavirus Infections (1)

Broader conditions

Female Urogenital Diseases (8)  ·  Female Urogenital Diseases and Pregnancy Complications (8)  ·  Genital Diseases (8)  ·  Genital Diseases, Female (8)  ·  Neoplasms (8)  ·  Precancerous Conditions (8)  ·  Urogenital Diseases (8)  ·  Uterine Cervical Diseases (8)  ·  Uterine Diseases (8)  ·  Disease Attributes (7)  ·  Genital Neoplasms, Female (7)  ·  Infections (7)  ·  Neoplasms by Site (7)  ·  Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)

Interventions

Vaccines (4)  ·  Papanicolaou Test (1)  ·  Papillomavirus Vaccines (1)  ·  hecolin (1)

Sponsors

Jun Zhang (5)  ·  Chang Gung Memorial Hospital (1)  ·  Xiamen Innovax Biotech Co., Ltd (1)  ·  Xiamen University (1)

Countries

China (7)  ·  Taiwan (1)

Top investigators

Ting Wu, Ph. D. (5)  ·  Yuemei Hu, Bachelor (2)  ·  Jun Zhang, Master (1)  ·  Ting Wu, Ph. D (1)  ·  Youlin Qiao, Ph.D (1)  ·  Yuemei Hu (1)

Results publications

PMID 36037823, PMID 39670565, PMID 41407728